Enrichment pattern of leachable trace metals in roadside soils of Miri City, Eastern Malaysia

This article presents the results on distribution and enrichment pattern of acid-leachable trace metals (ALTMs) from roadside soil of Miri city, Sarawak, East Malaysia. The city is one of the fastest developing in the Malaysian region with huge petroleum resources. ALTMs Fe, Mn, Cr, Cu, Ni, Co, Pb, Zn and Cd along with organic carbon and carbonates (CaCO3) were analyzed in 37 soil sediments collected from roadside. The enrichment of ALTMs [especially Cu (0.4-13.1 µg g-1), Zn (9.3-70.7 µg g-1), Pb (13.8-99.1 µg g-1)] in the roadside soils indicate that these metals are mainly derived from sources related to traffic exhausts, forest fires and oil refineries. The comparative study and enrichment pattern of elements indicates that Mn, Cu, Zn and Pb are enriched multi-fold than the unpolluted soil and Ni, Pb, Cd in some samples compared to Sediment Quality Guidelines like Lowest Effect Level (LEL) and Effects Range Low (ERL) in the region which is mainly due to the recent industrial developments in the region. © 2014 Springer-Verlag Berlin Heidelberg

Updated guidance regarding the risk ofAllergic reactions to COVID-19 vaccines and recommended evaluation and management: a GRADE assessment, and international consensus approach.

This guidance updates 2021 GRADE recomendations regarding immediate allergic reactions following COVID-19 vaccines and addresses re-vaccinating individuals with 1st dose allergic reactions and allergy testing to determine re-vaccination outcomes. Recent meta-analyses assessed the incidence of severe allergic reactions to initial COVID-19 vaccination, risk of mRNA-COVID-19 re-vaccination after an initial reaction, and diagnostic accuracy of COVID-19 vaccine and vaccine excipient testing in predicting reactions. GRADE methods informed rating the certainty of evidence and strength of recommenations. A modified Delphi panel consisting of experts in allergy, anaphylaxis, vaccinology, infectious diseases, emergency medicine, and primary care from Australia, Canada, Europe, Japan, South Africa, the UK, and the US formed the recommendations. We recommend vaccination for persons without COVID-19 vaccine excipient allergy, and re-vaccination after a prior immediate allergic reaction. We suggest against >15-minute post-vaccination observation. We recommend against mRNA vaccine or excipient skin testing to predict outcomes. We suggest re-vaccination of persons with an immediate allergic reaction to the mRNA vaccine or excipients be performed by a person with vaccine allergy expertise, in a properly equipped setting. We suggest against pre-medication, split-dosing, or special precautions because of a comorbid allergic history